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http://dxIntroduction: The efficacy of coronary artery bypass graft (CABG) surgery for patients with ischemic heart
disease is dependent on the patency of the selected conduit. The left internal thoracic artery is considered to
be the best conduit for CABG. However, the preferred conduit between the radial artery (RA) and saphenous
vein (SV) remains controversial. The present meta-analysis aims to establish the current level IA evidence on
patency outcomes comparing the RA and SV.
Methods: Electronic searches were performed using 6 databases from their inception to March 2012. Two re-
viewers independently identified all relevant randomized controlled trials (RCTs) comparing patency outcomes
of RA and SV grafts after CABG. Data were extracted and meta-analyzed according to angiographic end points
at specified follow-up intervals.
Results: Five relevant RCTs were identified for inclusion in the present meta-analysis. Angiographic results in-
dicated that the RAwas significantly more likely to be completely patent and less likely to be associated with
graft failure or complete occlusion at 4 years’ follow-up and beyond. However, the RAwas significantly more
likely to be associated with string sign at 1 year of follow-up.
Conclusions: While acknowledging the limitations of heterogeneous surgical techniques, results from the
present meta-analysis suggest potential superiority of the RA compared with the SV at midterm angiographic
follow-up. However, the increased incidence of string sign associated with the RA is of potential clinical con-
cern. Further research should be directed at correlating angiographic findings of string sign and graft failure to
clinical symptoms and major adverse cardiac and cerebrovascular events at long-term follow-up. (J Thorac Car-
diovasc Surg 2013;146:255-61)Coronary artery bypass graft (CABG) surgery remains the
gold standard treatment strategy for patients with left
main coronary artery disease and multivessel disease.1,2
The efficacy of CABG is dependent on the long-term pa-
tency of the selected conduits. The left internal thoracic
artery is established as the best conduit for CABG, particu-
larly for grafting the left anterior descending artery.3 After
initially unfavorable outcomes,4 there has been an emerging
and renewed enthusiasm for the radial artery (RA) as an al-
ternative conduit through the use of improved harvesting
techniques and antispasmodic medications.5
Although a number of retrospective studies have indi-
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The Journal of Thoracic and Caremains a lack of consistent and robust clinical data to
compare the RA to the saphenous vein (SV) for patients
who undergo CABG. Proponents of total arterial
revascularization highlight the superior clinical and
angiographic results using the RA9 whereas sceptics report
poor outcomes from large retrospective studies.10 The
present meta-analysis aims to provide level IA evidence
for the comparison of angiographic outcomes in RA versus
SV conduits for CABG.PATIENTS AND METHODS
Literature Search Strategy
Electronic searches were performed using Ovid MEDLINE, Cochrane
Central Register of Controlled Trials, Cochrane Database of Systematic
Reviews, ACP Journal Club, and Database of Abstracts of Review of Effec-
tiveness from their date of inception to March 2012. Only randomized con-
trolled trials (RCTs) were included in the present meta-analysis, as
recommended by the Centre for Evidence Based Medicine guidelines to
provide the highest level of clinical evidence.11 To achieve the maximum
sensitivity of the search strategy and identify all studies, we combined
the terms ‘‘radial artery’’ with ‘‘randomized controlled trial’’ as both key-
words andMeSH headings. The reference lists of all retrieved articles were
reviewed for further identification of potentially relevant studies. All rele-
vant articles identified were assessed with application of the inclusion and
exclusion criteria.12rdiovascular Surgery c Volume 146, Number 2 255
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
OR ¼ odds ratio
RA ¼ radial artery
RCT ¼ randomized controlled trial
SV ¼ saphenous vein
TIMI ¼ Thrombolysis in Myocardial Infarction
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Eligible RCTs for the present meta-analysis included those in which
patients with coronary artery disease underwent CABG using RAs and/
or SVs and assessed angiographically for patency. When centers have
published duplicate trials with accumulating numbers of patients or in-
creased lengths of follow-up, only the most updated reports were in-
cluded for qualitative appraisal at each time interval. To maintain the
consistency of measured end points, the chief investigators of this study
discussed angiographic definitions of ‘‘graft failure’’ before data analysis.
It is acknowledged that patient selection for revascularization varied
among institutions and sometimes within an institution at different time
periods. All publications were limited to human subjects. Non-English ar-
ticles were not excluded. Abstracts, case reports, conference presenta-
tions, editorials, and expert opinions were excluded. Review articles
were omitted owing to potential publication bias and possible duplication
of results.
Data Extraction and Critical Appraisal
All data were extracted from article texts, tables, and figures. When in-
sufficient data were available from publications, corresponding authors
were contacted to provide additional records. Two investigators indepen-
dently reviewed each retrieved article. Assessment of risk of bias for
each selected study was also independently performed by 2 investigators
according to the most updated Cochrane statement.13 Discrepancies be-
tween the 2 reviewers were resolved by discussion and consensus. The final
results were reviewed by the senior investigators.
Statistical Analysis
Meta-analysis was performed by combining the results of reported an-
giographic incidences of complete occlusion, string sign, graft failure, and
complete patency. The odds ratio (OR) was used as a summary statistic. In
the present study, both fixed- and random-effect models were tested. In
a fixed-effects model, it was assumed that treatment effect in each study
was the same, whereas in a random-effects model, it was assumed that there
were variations between studies and the calculated ratios thus had more
conservative value.14 c2 Tests were used to study heterogeneity betweenTABLE 1. Summary of study characteristics of RCTs comparing RA vers
First author
Year of
publication Country Study period
No.
randomiz
Desai16 2004 Canada/NZ 1996-2001 561
Gaudino17 2005 Italy 1994-1997 120
Collins18 2008 UK 1998-2000 147
Hayward19 2011 Australia 1996-2004 255
Goldman20 2011 US 2003-2009 757
RCT, Randomized controlled trial; RA, radial artery; SV, saphenous vein; CABG, coronary
MACE, major adverse cardiac events, including mortality, myocardial infarction and repe
256 The Journal of Thoracic and Cardiovascular Surgtrials. I2 statistic was used to estimate the percentage of total variation
across studies, owing to heterogeneity rather than chance. I2 can be calcu-
lated as: I2 ¼ 100%3 (Qdf)/Q, with Q defined as Cochrane’s heteroge-
neity statistics and df defined as degree of freedom.15 An I2 value of greater
than 50%was considered substantial heterogeneity. If therewas substantial
heterogeneity, the possible clinical and methodologic reasons for this were
explored qualitatively. In the present meta-analysis the results using the
random-effects model were presented to take into account the possible clin-
ical diversity and methodologic variation between studies. Specific analy-
ses considering confounding factors were not possible because raw data
were not available. All P values were 2-sided. All statistical analysis was
conducted with Review Manager Version 5.1.2 (Cochrane Collaboration,
Software Update, Oxford, United Kingdom).RESULTS
Quantity and Quality of Trials
A total of 512 references were identified through the 5
electronic database searches. After exclusion of duplicate
or irrelevant references, 43 potentially relevant articles
were retrieved. After detailed evaluation of these articles,
21 studies remained for assessment. Manual search of the
reference lists did not identify any additional relevant stud-
ies. After applying the selection criteria, 5 RCTs were se-
lected for analysis. The study characteristics of these
trials are summarized in Table 1. In these 5 studies, 1840 pa-
tients were randomized with 1708 angiographic results
available for analysis to compare RA (n ¼ 859) versus
SV (849) conduits in CABG. Surgical details and baseline
characteristics are summarized in Tables 2 and 3,
respectively.
The 5 RCTs were assessed qualitatively using tools de-
signed to measure the risk of bias, as recommended by
the Cochrane collaboration. A summary of selection bias,
performance bias, detection bias, attrition bias, reporting
bias, and other bias identified in each individual RCT is pre-
sented in Figures 1 and 2.Assessment of Complete Occlusion
Complete occlusion was not significantly different be-
tween the RA and SV at 12 months’ angiographic follow-
up (9.1% vs 12.7%; OR, 0.71; 95% confidence interval
[CI], 0.43-1.16; P ¼ .15; I2 ¼ 51%). However, beyond 4
years, the RAwas found to be associated with a significantly
lower risk for complete occlusion (2.7% vs 14.7%; OR,us SV as conduits for CABG surgery
ed
No.
analyzed RA SV
Angiographic
follow-up (mo)
Primary
end point
440 440 440 8-12 Graft occlusion
80 40 40 52 Graft patency
103 59 44 67 Graft occlusion
110 51 59 66 MACE
535 269 266 2-24 Graft patency
artery bypass grafting; NZ, New Zealand; UK, United Kingdom; US, United States;
at revascularisation.
ery c August 2013
TABLE 2. Summary of surgical techniques and grafted vessels in RCTs comparing RA versus SV as conduits for CABG surgery
First author Native coronary artery stenosis Territory grafted Elective CABG Surgical technique
Desai16 >70% proximal lesion RCA or LCx 67% NR
Gaudino17 >70% proximal lesion;>1 mm OM1 100% On pump 100%
Collins18 >70% proximal lesion LCx 100% On pump 100%
Hayward19 >70% proximal lesion;>1.5 mm Best coronary after LAD 71% RA, 81% SV On pump 100%
Goldman20 >70% proximal lesion Determined by surgeon 100% On pump 88%
RCT, Randomized controlled trial; RA, radial artery; SV, saphenous vein; CABG, coronary artery bypass grafting; RCA, right coronary artery; LCx, left circumflex artery; OM1,
first oblique marginal branch; LAD, left anterior descending artery; NR, not reported.
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beyond 4 years are summarized in Figure 3.
Assessment of String Sign
Angiographic finding of string sign was significantly
higher in the RA group than in the SV group at 12 months’
follow-up (7.4% vs 1.0%; OR, 7.97; 95% CI, 3.60-17.68;
P<.00001; I2¼ 0%), as well as a trend toward a higher in-
cidence at beyond 4 years’ follow-up (2.7% vs 0%; OR,
3.55; 95% CI, 0.57-22.11; P ¼ .17; I2 ¼ 0%). The results
at 1 year are summarized in Figure 4.
Assessment of Graft Failure
Graft failure from each individual RCT included patients
who had RA or SV grafts that were either completely oc-
cluded or had the string sign at the time of the follow-up an-
giography.16-20 In addition, patients who had angiographic
reports of Thrombolysis in Myocardial Infarction (TIMI)
flow of 1 to 2,16 those with compromised flow state of
more than 50%,18 stenosis of more than 80%,19 or stenosis
of more than 75%20 were also categorized as having failed
grafts. It is acknowledged that the angiographic end points
and methodology varied among institutions.16-20 However,
according to the aforementioned definitions, graft failure
was similar between the RA and SV at 12 months (18.4%
vs 15.5%; OR, 1.26; 95% CI, 0.78-2.03; P ¼ .34;
I2 ¼ 65%) but significantly less likely in patients who
had RA beyond 4 years’ follow-up (6.0% vs 17.5%; OR,
0.31; 95% CI, 0.14-0.68; P¼ .004; I2¼ 0%). These results
are summarized in Figure 5.
Assessment of Complete Patency
Although complete graft patency was found to be similar
between the RA and SV groups at 1 year (79.2% vs 82.5%;TABLE 3. Summary of patient baseline characteristics of RCTs comparin
Study
Age (y) Female Diabetes mellitus
RA SV RA SV RA SV
Desai16 61 57% 26%
Gaudino17*
Collins18 58 58 3% 5% 19% 14%
Hayward19 73 73 20% 14% 29% 39%
Goldman20 61 62 1% 1% 42% 42%
RCT, Randomized controlled trial; RA, radial artery; SV, saphenous vein; CABG, coronary
and SV groups. yEver smokers.
The Journal of Thoracic and CaOR, 0.79; 95% CI, 0.50-1.26; P ¼ .33; I2 ¼ 66%), the RA
was more likely to result in a completely patent graft than
was the SV beyond 4 years (89.9% vs 63.1%; OR, 5.19;
95% CI, 2.35-11.47; P<.0001; I2 ¼ 0%). The results be-
yond 4 years are summarized in Figure 6.
DISCUSSION
Carpentier and associates4 first described the use of the
RA in aorta-to-coronary artery bypass grafting in 1973 by
reporting the short-term outcomes of 40 grafts in 30 pa-
tients. The advantages of the RA compared with the SV
were duly noted, including the arterial structure, elasticity,
and regularity of the lumen. However, the RA as an alterna-
tive conduit was largely abandoned for decades owing to
concerns about spasm, early occlusion, and competitive
flow. Since then, an improved understanding of the natural
history of histologic changes in venous and arterial grafts
and pharmacologic implications of antispasmodic drugs
has culminated in a revival of the RA in the 1990s.5,21,22
In addition, revelation of the significant attrition rate of
the SV conduit has further encouraged the exploration of
arterial conduits.23 Despite enthusiasm for total arterial
revascularization from some centers, uncertainty regarding
the superiority of the RA compared with the SV used in
conventional CABG has prevented the widespread accep-
tance of the RA as a preferred conduit.10,24,25 A lack of
consensus among clinicians is partly reflected by the
fluctuating use of the RA for isolated CABG from 12.3%
in 2002 to 5.5% in 2009 according to The Society of
Thoracic Surgeons database.26
Benedetto and associates27 performed a meta-analysis of
RCTs from 4 centers comparing the RA and SV using graft
failure as the sole end point. This study did not include a re-
cent RCT involving the largest number of participants tog RA versus SV as conduits for CABG surgery
Hypertension Current smoker Previous MI
RA SV RA SV RA SV
46% 17% 46%
58% 50% 17% 5% 51% 45%
47% 61% 73%y 71%y NR NR
79% 79% 23% 27% 40% 39%
artery bypass grafting; MI, myocardial infarction. *No specific data available for RA
rdiovascular Surgery c Volume 146, Number 2 257
FIGURE 1. Methodologic quality graph summarizing the risk of bias from randomized controlled trials comparing radial artery versus saphenous vein for
coronary artery bypass graft surgery.
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different follow-up intervals. The authors concluded that
the RA and SV had similar graft failure rates but were crit-
icized for their methodology.28 More recently, Athanasiou
and associates performed a thorough systematic reviewFIGURE 2. Methodological quality summary of randomized controlled
trials comparing radial artery versus saphenous vein for coronary artery
bypass graft surgery.
258 The Journal of Thoracic and Cardiovascular Surgand meta-analysis of all randomized and nonrandomized
studies comparing the RA and SV, citing the inadequacy
of including only RCTs. This meta-analysis grouped
RCTs with retrospective observational studies, some of
which had controversial study designs and outcomes.10,29
The present meta-analysis aimed to assess the level IA clin-
ical evidence of the RAversus the SVusing multiple angio-
graphic patency end points at specified time intervals
according to recommended guidelines.11
Results of the present meta-analysis indicate that the RA
does not appear to be superior to the SVat 1 year of follow-
up, and indeed it is more likely to be associated with the
string sign, which is generally considered to be a form of
graft failure.30-32 However, the RA has significantly
superior angiographic patency outcomes compared with
the SV at 4 years and beyond, according to end points of
complete graft occlusion, graft failure, and complete
patency. Heterogeneity assessment of these long-term stud-
ies revealed a low degree of heterogeneity (I2 ¼ 0%) in all
measured outcomes. Overall, our findings are consistent
with previous observational studies that report superior out-
comes from total arterial revascularization compared with
conventional CABG using venous conduits, which becomes
more evident on longer follow-up.23
The significance of the angiographic string sign has long
been recognized, not only in conduits used in CABG but for
other systemic vascular diseases.33 Miwa and associates.34
retrospectively analyzed their data from the Radial Artery
Patency Study (RAPS) trial,16 which identified string sign
in 31 of 440 RA and 4 of 440 SV grafts (P ¼ .001). In their
study, string sign was defined a priori as a patent graft that
was diffusely narrowed, with a diameter less than 1 mm. It
was further categorized as ‘‘complete’’ if the narrowing was
along the full length of the graft or ‘‘partial’’ if only a seg-
ment was affected. Although the results of this study clearly
demonstrated a preponderance for string signs in RA grafts,
especially in patients with less than 90% narrowing of
the native coronary artery, the clinical impact of this angio-
graphic phenomenon was less clear. Clinical findings ofery c August 2013
FIGURE 3. Forest plot of the odds ratio (OR) of complete occlusion beyond 4 years after using radial artery (RA) versus saphenous vein (SV) as a conduit
during coronary artery bypass grafting. The estimate of the OR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95%
confidence interval (CI). On each line, the number of events as a fraction of the total number randomized is shown for both treatment groups. For each
subgroup, the sum of the statistics, along with the summary OR, is represented by the middle of the solid diamonds. A test of heterogeneity between
the trials within a subgroup is given below the summary statistics. M-H, Mantel-Haenszel.
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than the string sign itself. Furthermore, there was no signif-
icant difference in the incidence of myocardial infarction
between patients who had string signs compared with those
who did not, although the authors acknowledged limitations
owing to their relatively small sample size. Certainly, the
nonlinear correlation between TIMI flow and the incidence
of string sign suggests the cause may be multifactorial, such
as competitive collateral flow, translesional flow through
a small target artery, poor harvesting technique, or inherent
graft disease.30,31 Nonetheless, results from the present
study warrant further prospective studies that examine the
correlation of the string sign from RA conduits to
potentially significant clinical end points.
A number of limitations should be acknowledged about
the present study, and the results should be interpreted
with caution. First, patients from the RCTs included in
the present meta-analysis are a highly selected cohort who
underwent isolated CABG. Specifically, all patients had to
have a greater than 70% proximal lesion in the native cor-
onary vessel, inasmuch as it has been established that
patients with lower-grade lesions had an increased propen-
sity for competitive flow and were probably not suitable or
ethical for randomization.16-20 Second, graft patency isFIGURE 4. Forest plot of the odds ratio (OR) of string sign angiographic find
a conduit during coronary artery bypass grafting. The estimate of the OR of each
the 95% confidence interval (CI). On each line, the number of events as a fracti
each subgroup, the sum of the statistics, along with the summary OR, is represen
trials within a subgroup is given below the summary statistics. M-H, Mantel-H
The Journal of Thoracic and Cadependent on a number of important variables. These
include the type of conduit used, size of the native
coronary artery, the severity and location of disease, the
territory of the runoff, the surgical technique and
experience of the surgeon, and perioperative use of
antispasmodic medications, all of which differed among
studies. This may partly explain the heterogeneity
identified between the 2 large RCTs conducted by
Desai,16 Goldman,20 and their associates, the latter of which
included a significant proportion of patients who underwent
off-pump CABG. However, owing to the randomization
process, confounding factors were minimized within each
individual study, and the present meta-analysis represents
a summary of the highest level of evidence in the current
literature.
In view of our findings, we conclude that the RA offers
better midterm angiographic patency outcomes than does
the SV for selected patients with severe proximal lesions
in the setting of multivessel disease. However, their likeli-
hood of causing the string sign and the lack of clear evi-
dence on clinical end points such as major adverse
cerebrovascular and cardiac events warrants further ran-
domized studies with longer follow-up and measurement
of clinical outcomes. Future trials should also assessing at 1 year after using radial artery (RA) versus saphenous vein (SV) as
trial corresponds to the middle of the squares, and the horizontal line shows
on of the total number randomized is shown for both treatment groups. For
ted by the middle of the solid diamonds. A test of heterogeneity between the
aenszel.
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FIGURE 5. Forest plot of the odds ratio (OR) of graft failure beyond 4 years after using radial artery (RA) versus saphenous vein (SV) as a conduit during
coronary artery bypass grafting. The estimate of the OR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95% con-
fidence interval (CI). On each line, the number of events as a fraction of the total number randomized is shown for both treatment groups. For each subgroup,
the sum of the statistics, along with the summary OR, is represented by the middle of the solid diamonds. A test of heterogeneity between the trials within
a subgroup is given below the summary statistics. M-H, Mantel-Haenszel.
FIGURE 6. Forest plot of the odds ratio (OR) of complete patency beyond 4 years after using radial artery (RA) versus saphenous vein (SV) as a conduit
during coronary artery bypass grafting. The estimate of the OR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95%
confidence interval (CI). On each line, the number of events as a fraction of the total number randomized is shown for both treatment groups. For each
subgroup, the sum of the statistics, along with the summary OR, is represented by the middle of the solid diamonds. A test of heterogeneity between
the trials within a subgroup is given below the summary statistics. M-H, Mantel-Haenszel.
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apparent on short-term follow-up.35
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